Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Modafinil for Neurocognitive Deficits in Children with Brain Tumors
NCT01381718Phase 2Completed
- Sponsor
- University of South Florida
- Start
- Aug 2011
- Primary completion
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in cancer-related cognitive impairment (CRCI) and cancer-related fatigue (CRF) comparing Modafinil with Placebo (2 arms). Primary endpoint: Change in Age-Adjusted Scores in the Attention Task of the CogState Battery at 6 weeks. Started Aug 2011; status: completed.
02
Drugs
modafinil
03
Conditions
cancer-related cognitive impairment (CRCI)cancer-related fatigue (CRF)
Beyond the preview
Go deeper on NCT01381718.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01381718.